Jump to Main Content
Assessment of Egg Nutrient Compositional Changes and Residue in Eggs, Tissues, and Excreta Following Oral Administration of Atorvastatin to Laying Hens
- Elkin, Robert G., Furumoto, Emily J., Thomas, Charles R.
- Journal of agricultural and food chemistry 2003 v.51 no.11 pp. 3473-3481
- amino acids, bile, cholesterol, diet, drugs, egg albumen, egg yolk, eggs, excreta, fatty acid composition, heart, kidneys, laying hens, liver, nutrient content, oral administration
- Laying hens were fed a control diet alone or with 0.06 g of atorvastatin, a synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, per 100 g of diet for 20 days. Compared to controls, egg yolks from treated hens contained greater amounts of amino acids and reduced levels of total fatty acids and cholesterol. In contrast, egg albumen amino acid contents were unaffected by dietary treatments. In a residue study, seven hens each received a single oral dose of ~20 μCi of [14C]atorvastatin. Approximately 71% of the radioactivity was recovered in the excreta and liver, whereas virtually no radioactivity was detected in kidney, heart, muscle, bile, plasma, or egg albumen at 15 days postdosing. Yolk radioactivity peaked at 4 days postdosing in six of the seven birds and was absent in eggs laid after day 10. Reminiscent of that of certain antibiotic drugs, the atorvastatin egg residue pattern appeared to coincide with the physiological pattern of daily yolk accretion within the ovary.